Scorpius Holdings Files Definitive Proxy Statement

TL;DR

SCPX proxy statement filed, shareholders get voting info for 2025.

AI Summary

Scorpius Holdings, Inc. (formerly NightHawk Biosciences, Inc. and HEAT BIOLOGICS, INC.) filed a Definitive Proxy Statement (DEF 14A) on December 20, 2024, for the fiscal year ending December 31, 2025. The company, located at 627 Davis Drive, Suite 300, Morrisville, NC, operates in the Pharmaceutical Preparations sector. This filing is related to the company's proxy solicitation for its annual meeting.

Why It Matters

This filing provides shareholders with essential information regarding the company's governance and upcoming voting matters, allowing them to make informed decisions.

Risk Assessment

Risk Level: low — This is a routine regulatory filing (DEF 14A) providing information to shareholders, not indicating new financial risks.

Key Players & Entities

• Scorpius Holdings, Inc. (company) — Registrant
• NightHawk Biosciences, Inc. (company) — Former Company Name
• HEAT BIOLOGICS, INC. (company) — Former Company Name
• 20250116 (date) — Conformed Period of Report
• 20241220 (date) — Filed as of Date
• 20241219 (date) — Date as of Change
• 0001476963 (company) — Central Index Key
• 2834 (industry_code) — Standard Industrial Classification
• 262844103 (irs_number) — IRS Number
• DE (state) — State of Incorporation

FAQ

Key Financial Figures

• $0.0002 — nding shares of common stock, par value $0.0002 per share (“Common Stock”),
• $15,000 — King & Co., Inc. fees of not more than $15,000 plus expense reimbursement for its serv

Filing Documents

• scpx_def14a.htm (DEF 14A) — 208KB
• image_001.jpg (GRAPHIC) — 6KB
• image_002.jpg (GRAPHIC) — 5KB
• image_003.jpg (GRAPHIC) — 81KB
• image_004.jpg (GRAPHIC) — 55KB
• 0001079973-24-001744.txt ( ) — 412KB

SECURITY OWNERSHIP OF MANAGEMENT AND CERTAIN BENEFICIAL OWNERS

SECURITY OWNERSHIP OF MANAGEMENT AND CERTAIN BENEFICIAL OWNERS 22 NOTICE REGARDING DELIVERY OF STOCKHOLDER DOCUMENTS (“HOUSEHOLDING” INFORMATION) 25 STOCKHOLDER PROPOSALS FOR THE 2025 ANNUAL MEETING 26 APPENDIX A A-1 i 627 Davis Drive, Suite 300 Morrisville, North Carolina 27560 PROXY For the Special Meeting of Stockholders to be held on JANUARY 16, 2025 General Information We are providing these proxy materials to holders of shares of common stock, $0.0002 par value per share (“Common Stock”), of Scorpius Holdings, Inc., a Delaware corporation (referred to as “Scorpius,” the “Company,” “we,” or “us” and formerly known as NightHawk Biosciences, Inc. and as Heat Biologics, Inc.), in connection with the solicitation by the Board of Directors of Scorpius (the “Board of Directors” or the “Board”) of proxies to be voted at our special meeting of stockholders (the “Special Meeting”) to be held on January 16, 2025, beginning at 10:00 a.m. Eastern Time at Scorpius’ offices located at 627 Davis Drive, Suite 300, Morrisville, North Carolina 27560, and at any adjournment or postponement of the Special Meeting. This proxy statement is being distributed and made available to our stockholders starting on or about December 19, 2024. The purpose of the Special Meeting and the matters to be acted on are summarized below. No other business will come before the Special Meeting. Agenda Item Board Vote Recommendation Page Reference Reverse Stock Split Proposal FOR 6 Share Issuance Proposal FOR 18 Adjournment Proposal FOR 21 Even if you plan to attend the Special Meeting, please vote in advance so that your vote will be counted if you later decide not to attend the Special Meeting. Special Meeting Admission Only stockholders as of December 13, 2024 (the “Record Date”) may attend the Special Meeting. If you att

View Full Filing

View this DEF 14A filing on SEC EDGAR